CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel ) in Autoimmune Diseases and Hematologic Malignancies 22 December 2025
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results 10 November 2025